Channelrhodopsin-2, a Directly Light-gated Cation-selective Membrane Channel
Overview
Authors
Affiliations
Microbial-type rhodopsins are found in archaea, prokaryotes, and eukaryotes. Some of them represent membrane ion transport proteins such as bacteriorhodopsin, a light-driven proton pump, or channelrhodopsin-1 (ChR1), a recently identified light-gated proton channel from the green alga Chlamydomonas reinhardtii. ChR1 and ChR2, a related microbial-type rhodopsin from C. reinhardtii, were shown to be involved in generation of photocurrents of this green alga. We demonstrate by functional expression, both in oocytes of Xenopus laevis and mammalian cells, that ChR2 is a directly light-switched cation-selective ion channel. This channel opens rapidly after absorption of a photon to generate a large permeability for monovalent and divalent cations. ChR2 desensitizes in continuous light to a smaller steady-state conductance. Recovery from desensitization is accelerated by extracellular H+ and negative membrane potential, whereas closing of the ChR2 ion channel is decelerated by intracellular H+. ChR2 is expressed mainly in C. reinhardtii under low-light conditions, suggesting involvement in photoreception in dark-adapted cells. The predicted seven-transmembrane alpha helices of ChR2 are characteristic for G protein-coupled receptors but reflect a different motif for a cation-selective ion channel. Finally, we demonstrate that ChR2 may be used to depolarize small or large cells, simply by illumination.
Phototropin connects blue light perception to starch metabolism in green algae.
Yuan Y, Iannetta A, Kim M, Sadecki P, Arend M, Tsichla A Nat Commun. 2025; 16(1):2545.
PMID: 40087266 DOI: 10.1038/s41467-025-57809-3.
Lee J, Kim T, Cho S, Shin J, Yeo W, Kim T Bioact Mater. 2025; 48:217-241.
PMID: 40046014 PMC: 11880665. DOI: 10.1016/j.bioactmat.2025.02.006.
Restoring vision with optogenetics.
Drew L Nature. 2025; 639(8053):S7-S9.
PMID: 40044898 DOI: 10.1038/d41586-025-00656-5.
Light-based technologies in immunotherapy: advances, mechanisms and applications.
Frumento D, talu S Immunotherapy. 2025; 17(2):123-131.
PMID: 40032620 PMC: 11901425. DOI: 10.1080/1750743X.2025.2470111.
Langen J, Boyle P, Malan D, Sasse P Sci Adv. 2025; 11(9):eadt4103.
PMID: 40020054 PMC: 11870084. DOI: 10.1126/sciadv.adt4103.